“This historical evaluation suggests that the EPA did not want to have its hands tied or its scientific image affected by statements from the 1960 BEAR Genetics and Medicine Panels that there was too much uncertainty to estimate cancer risk in the low dose zone. Their comments were simply ignored and swept under the regulatory rug.”
